Generic drugs approved by FDA (through May 2011): bromfenac ophthalmic solution 0.09%, sodium ferric gluconate complex in sucrose injection, nitrofurantoin oral suspension
Bromfenac ophthalmic solution 0.09% (twice-daily administration) (equiv to Xibrom Ophthalmic Solution, 0.09% (Twice-Daily Administration)
MYLAN
Sodium ferric gluconate complex in sucrose injection (Nulecit) in 5-mL glass ampules (equiv to Ferrlecit)
WATSON
Nitrofurantoin Oral Suspension in 25 mg/5 mL strength (equiv to Furadantin)
AMNEAL
FDA Issues Complete Response Letter for Pz-Cel to Treat Epidermolysis Bullosa
April 22nd 2024Prademagene zamikeracel is a cell therapy designed to incorporate the functional collagen-producing COL7A1 gene into a patient’s own skin cells. The FDA is asking for additional information on manufacturing practices.
Read More
FDA Approves Stelara Biosimilar, Selarsdi
April 18th 2024Alvotech’s Selarsdi (ustekinumab-aekn), a biosimilar referencing Stelara (ustekinumab), gained FDA approval, making it the second ustekinumab biosimilar and second for the company to be given the green light for the American market.
Read More